Navigation Links
Sangamo BioSciences Initiates Phase 2 Clinical Trial of Treatment for Amyotrophic Lateral Sclerosis (ALS)
Date:9/3/2008

ies," said Edward Lanphier, Sangamo's president and CEO. "VEGF has been demonstrated to have a fundamental role in the growth and health of blood vessels, nerves and muscle and we believe that our approach of using a ZFP TF to stimulate the expression of all of the natural forms of a subject's own VEGF-A gene may have potential therapeutic benefit for a variety of neurodegenerative conditions including ALS."

About the Study, SB-509-801

A total of 40 subjects with ALS will be enrolled in this trial and randomized into one of two treatment cohorts. The first cohort of 35 subjects will receive 60 mg of SB-509 in a divided dose into muscles in the arm, leg, and along the spine on both sides of the body. A second cohort of 5 subjects will receive 60 mg of SB-509 in a divided dose into the muscles in the lower limb in both legs. Each subject will receive a total of two treatments of 60 mg of SB-509 intramuscularly three months apart on Day 0 and Day 90. The study will be carried out over 11 months, including 2 months for screening, 3 months for two study treatments, and 6 months of follow-up after administration of the final dose. Individuals interested in participating in this trial should visit http://www.clinicaltrials.gov/ or http://www.alsa.org

About Amyotrophic Lateral Sclerosis (ALS)

More than 30,000 Americans have ALS, according to the ALS Association, a nonprofit organization that supports ALS research and public and patient education about the disease. 3,000 to 5,000 new cases of the disease are diagnosed every year. Men and women of all ethnic and racial groups are equally affected, usually between the ages of 40 and 70. The disease attacks the motor nerves, nerve cells in the brain and spinal cord that control the body's voluntary muscles. As the motor nerves begin to die, the muscles weaken and shrink. Early symptoms of ALS ma
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
2. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
3. Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
4. Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of Knock-Out Cell Lines
5. Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
6. Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
7. Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
9. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
10. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
11. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... , Sept. 30, 2014 BioStructures, LLC ... American Association of Tissue Banks (AATB), it was ... Executive Officer. Accreditation follows an intensive ... specially trained AATB inspector.  It establishes that the ... the facility meets or exceeds the standards set ...
(Date:9/30/2014)... , Sept. 30, 2014  Proteomics is a ... a new report from Kalorama Information.  The healthcare market ... occurred in proteomics in the past two years.  ... agreements between private proteomic companies and academic institutions, ... novel proteomics innovator companies.  Kalorama observed the industry ...
(Date:9/30/2014)... , September 30, 2014 ... the CSF (Cerebrospinal Fluid) backflow of the Eldor spinal ... of the single hole pencil point spinal needles of ... Braun. Spinal anesthesia is an excellent type ... Orthopedics, Urology, General Anesthesia, etc. It is ...
Breaking Medicine Technology:Biostructures, LLC Earns AATB Accreditation 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 3
... YORK, March 28, 2011 Havas Drive, the innovation ... of patient-centric services geared toward persons with disabilities and ... Smith—a nationally recognized authority on Web accessibility with a ... Pentagon Library, Kent State,s Knowledge Management program and the ...
... Inc. (Nasdaq: KERX ) (the "Company") today ... presented at the upcoming 102nd annual meeting of the ... in Orlando, Florida, from April 2-6, 2011. Perifosine, the ... Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, is ...
Cached Medicine Technology:Havas Drive Launches New Services Aimed at Improving Digital and Web Accessibility 2Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting 2Keryx Biopharmaceuticals Announces Two Poster Presentations on KRX-0401 (Perifosine) at Upcoming American Association for Cancer Research (AACR) Annual Meeting 3
(Date:9/30/2014)... to slow the spiraling costs of drugs paid for ... had no meaningful impact on cancer chemotherapy drug costs, ... of Clinical Oncology published online today. , "We ... and lung cancers, and did not find a substantial ... implementation of the recent Medicare law in 2005," says ...
(Date:9/30/2014)... by UC Irvine immunologists reveals new information about how ... process that determines how the body,s ability to fight ... Nature Immunology , neurology professor Dr. Michael Demetriou, postdoctoral ... describe a critical mechanism underlying how T cells are ... T cell is a type of blood cell called ...
(Date:9/30/2014)... 2014 Fat Burning Kitchen , the ... author Mike Geary that is helping people learn the truth ... a fat-burning machine in less than 24 hours has caught ... , “In our culture that is becoming so obsessed with ... what is really fact and fiction when it comes to ...
(Date:9/30/2014)... September 30, 2014 Hospice & ... annual “In Celebration” gala, honoring three outstanding individuals ... of striving to provide extraordinary and dignified comfort, ... a serious or life-limiting illness. , The event ... Rye, NY and recognized William (Bill) J. McGuinness, ...
(Date:9/30/2014)... Florida (PRWEB) September 30, 2014 Two revolutionary ... the treatment of gum disease a far less ... the past. , “If you’ve ever felt electric shock waves ... or sip a cold beverage, it’s possible you already know ... , who is a general dentist in West Palm Beach, ...
Breaking Medicine News(10 mins):Health News:Landmark Medicare law had little impact on reducing chemotherapy cost 2Health News:UCI study uncovers important process for immune system development 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 2Health News:Fat Burning Kitchen: Review Exposes Mike Geary’s 24-Hour Diet Transformation for Helping the Body Burn Fat Through a Natural Diet 3Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 3
... Painful endometriosis in women could be treated with a ... results of their study have been// published in the ... endometriosis have endometrial tissue developing outside the uterus, which ... a result there is often pain, bleeding, inflammation, infertility ...
... A strong warning was issued by Britain's prime minister to ... that were not-so- healthy to children or face// the risk ... that target minors. ,In a broad address on ... the voluntary regulations failing, the food industry would be forced ...
... used to get a second opinions on mammogram images, which ... slow. // ,In order to speed up the process, ... is able to get useful information from a mammogram database ... image in question to every image of breast cancer in ...
... the Albert Einstein College of Medicine of Yeshiva University ... the malaria disease by using their previous research on ... the August issue of Nature Methods, “should substantially speed ... to Dr. David Fidock, senior author of the paper ...
... experience sharp changes in their hormones once they start ... small monkeys.// ,Yevgenia Kozorovitskiy and her colleagues from ... - small monkeys that live in trees - that ... Scientist. ,The species is rare among mammals ...
... Curie Cancer Care hospice in Belfast, which has marked a major ... provisions for 18 individual en-suite rooms each of which open out ... provide for a family member to stay overnight with the patient. ... claimed that there were still more improvements to come. ...
Cached Medicine News:Health News:Google-Like Model Used To Diagnose Suspicious Breast Masses Quickly 2Health News:Malaria Truths Discovered By Einstein Researchers 2
... is a powerful magnifier that helps the partially sighted ... a hand magnifier attached to a pair of electronic ... no need for a TV set. The display is ... on a book, a can of food, a medicine ...
... vision to see objects at a distance, ... between. This battery operated system can be ... used as a desktop video magnifier when ... easy to use and requires no special ...
... general purpose incubators designed to ... and uniformity required for the ... versatile microprocessor controlled incubators feature ... easy-to-read digital display, and built-in ...
... general purpose incubators designed to ... and uniformity required for the ... versatile microprocessor controlled incubators feature ... easy-to-read digital display, and built-in ...
Medicine Products: